Cynthia Matossian, MD, FACS, ABES


Novel vehicle contributes to cyclosporine efficacy

Study shows improvements in signs, symptoms after 3 months of treatment

Where to start with treating OSD patients

Cynthia Matossian, MD, FACS, advises on how ophthalmologists can start performing a better diagnosis of ocular surface disease in three simple steps.

Evaluating and treating tear film patients with success

Cynthia Matossian, MD, FACS, explains why she believes if ophthalmologists consistently evaluate the ocular surface, tear film and lid margins—and treat any problems that we find—surgical outcomes will improve.

When at first you don’t succeed with MGD patients, keep trying

September 23, 2020

It's not always easy to convince early-stage, minimally symptomatic or symptomatic patients that their MGD should be treated. Cynthia Matossian, MD, FACS, explains why ophthalmologists shouldn't take this personally and how not to accept their denial as a final answer.